Alaunos Therapeutics, Inc. Land Subject to Ground Leases
Alaunos Therapeutics, Inc. (TCRT) had Land Subject to Ground Leases of 9.80 thousand sqft as of 2021-04-30, per its 10-Q filed 2021-08-13.
Discontinued › Notes
us-gaap:LandSubjectToGroundLeases · last filed 2021-11-08
- 2021-04-30: Land Subject to Ground Leases 9.80K sqft.
- 2021-04-22: Land Subject to Ground Leases 9.80K sqft.
- 2019-03-12: Land Subject to Ground Leases 1.04K sqft.
| Period end | Land Subject to Ground Leases |
|---|---|
| 2021-04-30 | 9.80K sqft 10-Q · filed 2021-08-13 |
| 2021-04-22 | 9.80K sqft 10-Q · filed 2021-11-08 |
| 2019-03-12 | 1.04K sqft 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |